Recent successes in therapeutics for Ebola virus disease: no time for complacency
Item
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
- Item Type
- Publication
- Terms of Use
- By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Stable Link to this Asset
Information about this resource
- Title
- Recent successes in therapeutics for Ebola virus disease: no time for complacency
- Subject
- Research
- Description
- The PALM trial in the Democratic Republic of the Congo identified a statistically significant survival benefit for two monoclonal antibody-based therapeutics in the treatment of acute Ebola virus disease; however, substantial gaps remain in improving the outcomes of acute Ebola virus disease and for the survivors.
- Date
- 2020-06-18
- Citation
- Iversen, Patrick L., Christopher D. Kane, Xiankun Zeng, Rekha G. Panchal, Travis K. Warren, Sheli R. Radoshitzky, Jens H. Kuhn, Rajini R. Mudhasani, Christopher L. Cooper, Amy C. Shurtleff, Farooq Nasar, Melek M. E. Sunay, Allen J. Duplantier, Brett P. Eaton, Elizabeth E. Zumbrun, Sandra L. Bixler, Shannon Martin, J. Matthew Meinig, Chih-Yuan Chiang, Mariano Sanchez-Lockhart, Gustavo F. Palacios, Jeffrey R. Kugelman, Karen A. Martins, Margaret L. Pitt, Ian Crozier, and David L. Saunders. 2020. "Recent successes in therapeutics for Ebola virus disease: no time for complacency." The Lancet Infectious Diseases.
- Accessibility
- Free online on Lancet site.
Was this resource helpful?